Professor Ansu Satpathy is a co-founder of Cartography Biosciences. Ansu is a physician-scientist who has pioneered the development and use of high-throughput genome sequencing technologies to study cancer immunology. Ansu is an Assistant Professor in the Department of Pathology at Stanford University. He is an investigator in the Gladstone-UCSF Institute of Genomic Immunology, the Parker Institute for Cancer Immunotherapy, and the Stanford Cancer Institute. In his spare time, he enjoys spending time with his children and cheering on the Warriors.
Recent Posts
- Cartography Biosciences Announces Strategic Investment From Samsung Ventures to Advance Oncology Pipeline
- Cartography Biosciences Advances Strategic Oncology Collaboration with Gilead’s First Option Target Exercise
- Cartography Biosciences Doses First Patient in Phase 1 Trial of CBI-1214, a Highly Specific T-Cell Engager for the Treatment of Colorectal Cancer
- Cartography Biosciences and Pfizer to Collaborate on the Discovery of Tumor-Selective Antigens
- Cartography Receives FDA Investigational New Drug (IND) Approval and Fast Track Designation for Lead Program CBI-1214 for Colorectal Cancer
Recent Comments
No comments to show.